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ABSTRACT 
Contaminated food and water ingestion and inhalation of polycyclic aromatic hydrocarbon are the main sources of human exposure 
to benzo(a)pyrene leading to cause renal injury and provoking a nephropathic response. Mangiferin is a highly potent antioxidant 
present in mango and known for several medicinal properties. The present study was undertaken to evaluate the renoprotective effect 
of mangiferin against benzo(a)pyrene induced toxicity. Benzo(a)pyrene was administered at a dose of 120.0 mg/kg once alone or in 
combination with mangiferin at 10.0 and 20.0 mg/kg for seven days in Swiss albino mice. Exposure to benzo(a)pyrene decreased the 
activities of glutathione peroxidase and increased glutathione-S-transferase level in the kidneys of mice. Moreover, DNA alkaline 
unwinding assay exhibit a significant decrease in F-value for the toxic control group in comparison to the normal mice, which is a 
marker for alteration in DNA integrity. Benzo(a)pyrene treatment also revealed an increased number of micronuclei in 
polychromatic erythrocytes in comparison with the control group indicating chromosomal damage in erythrocytes of bone marrow. 
Mangiferin pretreatment significantly improved the renal mitochondrial antioxidant status and restored the renal DNA integrity, thus 
demonstrating the protective effect in benzo(a)pyrene-treated mice. Dietary inclusion of mangiferin could exert protective effects 
against renal toxicity resulting from benzo(a)pyrene exposure.  
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INTRODUCTION 
Benzo(a)pyrene [B(a)P] is a polycyclic aromatic 
hydrocarbon known worldwide for its environmental 
contaminant property. Incomplete combustion of 
carbonaceous materials by humans for energy and 
barbeque, industrial ignition products and diesel exhaust 
are the chief ecological sources of B(a)P.
1-3
 The 
ingestion of contaminated food and water and inhalation 
of polycyclic aromatic hydrocarbon are the main source 
of human exposure to B(a)P
 
leading to cause renal 
injury
4
 and provoking a nephropathic response.
5
 Nanez 
et al. (2005) reported renal changes in female Sprague 
Dawley rats following once weekly injections of 10 
mg/kg B(a)P for 16 weeks.
6
 Previous toxicological 
studies demonstrated the possible metabolic activation 
of B(a)P to reactive intermediates similar to the liver 
cells. Moreover, B(a)P-induced nephropathy was 
demonstrated to involve disruption of glomerular cell–
cell and cell–matrix interactions in rats. A single oral 
administration of B(a)P at the dose of 125 mg/kg caused 
renal toxicity and loss of DNA integrity in mice.
7
 Renal 
toxicity in rodents induced by B(a)P treatment has 
become popular paradigm to study protective efficacy of 
various novel possible therapeutic candidates.   
There is considerable scientific evidence to suggest that 
compounds isolated from plants can inhibit the process 
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of many diseases effectively.
8 
Xanthones are naturally 
synthesized in various biological systems such as plants, 
lichens and fungi and are stored as byproducts. In 
addition to taxonomic significance, they are also 
important in the treatment/management of a number of 
human disorders. Mangiferin belongs to xanthones, 
known as a privileged class of secondary metabolites. 
Initially, it was isolated primarily from the Mangifera 
indica but it is also present in the plants of 16 other 
families including Anacardiacae, Gentianaceae and 
Iridaceae. It is considered one of the main active 
constituents in more than 40 polyherbal formulations in 
traditional Chinese medicine.
9 
Mangiferin has proven its 
effectiveness as an antioxidant, analgesic, antidiabetic, 
antiproliferative, chemopreventive, radioprotective, 
cardiotonic, immunomodulatory and diuretic agent. It is 
a potent antioxidant agent and also stimulates 
mitochondrial respiration and suppresses oxidative and 
inflammation damage.
10 
Keeping this in mind, 
mangiferin was chosen to evaluate its protective effect 
on B(a)P-induced renal toxicity. A series of indices 
related to oxidative stress, renal and DNA integrity were 
chosen to elucidate the protective effect of mangiferin 
on B(a)P-induced toxicity in rodents to provide a means 
of protection against environmental B(a)P-induced renal 
damage and to generate more comprehensive and 
reliable data for toxicological risk evaluation and 
protection by mangiferin. 
MATERIALS AND METHODS 
Chemicals 
Genistein (purity: ≥98%) and B(a)P (purity: ≥96%), 
were purchased from Sigma-Aldrich Chemicals Pvt. 
Ltd., Bangalore, India. All other chemicals and reagents 
used were of analytical grade. Mangiferin was 
solubilized in 1% DMSO and B(a)P in corn oil. All 
other chemicals were dissolved in double distilled water. 
The doses for all freshly prepared drug solutions were 
expressed in terms of their free bases. 
Subjects 
Swiss albino male mice (25-30 g and 8 weeks or older) 
were used in this study. Animals were grouped six mice 
per cage and maintained at standard conditions of 
humidity (55 ± 5%), temperature 24 ± 2 °C under 12:12 
h light/dark cycle. Animals have free access to rodent 
chow and tap water ad libitum. Animal studies were 
conducted after getting approval from Institutional 
Animal Ethics Committee. 
Treatment schedule 
Animals were divided into five groups consisting six 
animals each. 
Group I [Normal Control]: animals of this group were 
treated with corn oil (p.o.) for seven days. 
Group II [Toxic Control]: animals of this group were 
administered single oral dose of B(a)P (125.0 mg/g) on 
the first day of experimental period to induce 
renotoxicity [7], followed by a single oral dose of B(a)P 
(125.0 mg/g) on the eighth day. 
Group III [B(a)P + M (10)]: animals of this group were 
pretreated with mangiferin (10.0 mg/kg, i.p.) for seven 
days, followed by a single oral dose of B(a)P (125.0 
mg/g) on the eighth day. 
Group IV [B(a)P + M (20)]: animals of this group were 
pretreated with mangiferin (20.0 mg/kg, i.p.) for seven 
days, followed by a single oral dose of B(a)P (125.0 
mg/g) on the eighth day. 
Group V [M (20)]: animals of this group were pretreated 
with mangiferin (20.0 mg/kg, i.p.) for seven days. 
The above-mentioned doses of mangiferin were selected 
based on preliminary studies carried out in our 
laboratory. Acute and chronic toxicity studies and 
pharmacological studies
11
 conducted on mangiferin 
were used as reference in deriving the current doses. 
Assessment of mitochondrial integrity 
Post-mitochondrial supernatant and microsome 
preparation 
Tissue processing and preparation of post-mitochondrial 
supernatant (PMS) were done as described by Athar and 
Iqbal (1998). After the treatment period, kidneys were 
removed quickly, cleaned free of extraneous material 
and immediately perfused with ice-cold saline (0.85% 
sodium chloride). The kidneys were homogenized in 
chilled phosphate buffer (0.1 M, pH 7.4) containing KCl 
(1.17%) using homogenizer. The homogenate was 
filtered through muslin cloth and was centrifuged at 800 
g for 5 min at 4 °C to separate the nuclear debris. The 
aliquot so obtained was centrifuged at 12000 rpm for 20 
min at 4 °C to obtain post-mitochondrial supernatant 
(PMS), which was used as a source of enzymes. A 
portion of the PMS was centrifuged for 60 min by 
ultracentrifuge at 34000 rpm at 4 °C. The pellet was 
washed with phosphate buffer (0.1 M, pH 7.4) 
containing KCl (1.17%). All the biochemical 
determination were completed within 24 h of animal 
sacrifice.
12
 
Assay for glutathione peroxidase activity (Phase I 
enzyme) 
Glutathione peroxidase (GPx) activity was measured by 
the method of Mohandas et al. (1984). The reaction 
mixture consisted of 1.44 ml phosphate buffer (0.1 M, 
pH 7.4), 0.1 ml EDTA (1 mM), 0.1 ml sodium azide (1 
mM), 0.05 ml glutathione reductase (1 IU/ml), 0.05 ml 
reduced glutathione (1 mM), 0.1 ml NADPH (0.2 mM), 
0.01 ml H2O2 (0.25 mM) and 0.1 ml 10% PMS in a total 
volume of 2 ml. The disappearance of NADPH at 340 
nm was recorded at 25 °C. Enzyme activity was 
calculated as nmol NADPH oxidized/min/mg protein 
using a molar extinction coefficient of 6.22 × 
10
3
/M/cm.
13
 
Assay for glutathione-S-transferase activity (Phase II 
enzyme) 
Glutathione-S-transferase (GST) activity was assayed by 
the method of Habig (1974). The reaction mixture 
consisted of 1.475 ml phosphate buffer (0.1 M, pH 6.5), 
0.2 ml reduced glutathione (1 mM), 0.025 ml, 1,chloro-
2,dinitrobenzene (CDNB) (1 mM) and 0.3 ml PMS 
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(10% w/v) in a total volume of 2.0 ml. The changes in 
the absorbance were recorded at 340 nm and enzyme 
activity was calculated as nmol CDNB conjugate 
formed per minute per mg protein using a molar 
extinction coefficient of 9.6 × 10
6
/M/cm.
14
 
Assessment of DNA integrity 
DNA Isolation 
DNA was extracted from approximately 500 mg of 
kidney tissue by homogenizing the tissue in 5 ml TNE 
buffer (50 mM Trisma, 100 mM EDTA, 0.5% SDS, pH 
8.0) in a 2 ml ground glass homogenizer. Each sample 
was homogenized with 10 standardized strokes of the 
pestle to minimize any potential effect on DNA integrity 
introduced by the homogenization procedure. An equal 
volume of buffered phenol/chloroform/isoamyl alcohol 
(PCI) (25:24:1, v/v/v, pH 8.0) was then added to the 
sample. The sample was gently mixed and allowed to 
settle for 5 min. It was then centrifuged for 5 min at 
13000 rpm at 4 °C. The aqueous layer was transferred to 
a new micro centrifuge tube and PCI extraction was 
repeated. The aqueous layer was then digested by 5 ml 
of RNAase (10 mg/ml) for 30 min at 37 °C and the 
digest was extracted once by PCI and once by 500 ml of 
chloroform. DNA was precipitated from the resulting 
aqueous layer by adding 2 volumes of absolute ethanol 
and 1/10 volume of 3 M sodium acetate, pH 5.2. The 
sample was then centrifuged (13000 rpm, 15 min) and 
the resulting pellet rinsed with 500 ml of 70% ethanol 
and air-dried. The amount of DNA was quantitated 
spectrophotometrically at 260 and 280 nm. Two mg/ml 
of DNA sample was dissolved in 1 ml of TE buffer (10 
mM Trisma, 1 mM EDTA) and subsequently used in the 
DNA alkaline unwinding assay.
15
 
Alkaline unwinding assay 
The procedure used alkaline unwinding was essentially 
the same as that outlined by Shugart (1988) with slight 
modifications. In the alkaline unwinding assay, the rate 
of transition of double stranded DNA (dsDNA) to single 
stranded DNA (ssDNA) under pre-defined alkaline 
denaturing condition was proportional to the number of 
breaks in the phosphodiester backbone and thus was 
used as a measure of DNA integrity. Bisbenzamide was 
used as a DNA-binding dye and from its fluorescence, 
various types of DNA were quantitated. For the 
fluorescence determination of dsDNA, ssDNA and 
partially unwound DNA (au-DNA), three equal portions 
of diluted DNA sample were prepared. The amount of 
dsDNA was obtained from the fluorescence of a sample 
without any treatment; while ssDNA was determined 
from the sample that had been boiled for 30 min. 
Fluorescence of the DNA sample, which had been 
subjected to alkaline treatment (pH 12.2) on ice for 30 
min provided an estimate of the amount of auDNA. The 
fluorescence of initial or dsDNA was determined by 
placing 100 mmol DNA sample, 100 ml NaCl (25 mM) 
and 2 ml SDS (0.5%) in a pre-chilled test tube, followed 
by addition of 3 ml 0.2 M potassium phosphate pH 9, 
and 3 ml bisbenzamide (1 mg/ml). The contents were 
mixed and allowed to react in darkness for 15 min to 
allow fluorescence to stabilize. The fluorescence of the 
sample was measured using a spectrofluorimeter (Ex: 
360 nm, Em: 450 nm). The fluorescence of single 
stranded DNA was determined as above but using the 
DNA sample that had already been boiled for 30 min to 
completely unwinds the DNA. The amount of 0.50 ml 
NaOH (0.05 N) was rapidly mixed with 100 ml of the 
DNA sample in a pre-chilled test tube. The mixture was 
incubated on ice in darkness for 30 min [15] followed 
by rapid addition and mixing of 50 ml HCl (0.05 N). 
This was followed immediately by addition of 2 ml SDS 
(0.5%) and the mixture was forcefully passed through a 
21 G needle six times. Fluorescence of alkaline 
unwounded DNA sample was measured as described 
above. Measurement of the alkaline unwounded sample 
was performed in triplicate and the average was 
reported. The ratio between dsDNA to total DNA (F-
value) was determined as follows: 
F value = (auDNA – ssDNA)/(dsDNA – ssDNA) 
Where, auDNA, ssDNA and dsDNA were the degrees 
of fluorescence from the partially unwound, single 
stranded and double stranded determinations, 
respectively. The F value was inversely proportional to 
the number of strand breaks present and thus could be 
used as an indicator of DNA integrity.
16
 
Micronucleus test 
The mouse bone marrow micronucleus test was carried 
out according to the method of Schimid (1975). For this 
test, mice were sacrificed 24 h after treatment with 
single oral dose of B(a)P. Femur bones for bone marrow 
were collected for micronucleus assay and kidney tissue 
for enzymatic assay. The cells were smeared on glass 
slide, air-dried and then stained successively with May-
Gruenwald and Giemsa stain. Per animal, 2000 
polychromatic erythrocytes (PCEs) were scored to 
determine the frequency of micronucleated 
polychromatic erythrocytes (MNPCEs) and the ratio of 
PCE/NCE was counted in 200 normochromatic 
erythrocytes (NCEs). A total of 2500-3000 
polychromatic erythrocytes (PCEs) were scored per 
animal by the same observer for determining the 
frequencies of micronucleated polychromatic 
erythrocytes (MnPCEs).
17
 
Statistical analysis 
Differences between groups were analyzed using 
analysis of variance (ANOVA) followed by Tucky’s 
multiple comparisons test. All data points are presented 
as the treatment groups mean ± standard error of the 
mean (SEM). Probability values less than 0.05 were 
considered statistically significant in all the cases. 
RESULTS 
Assessment of mitochondrial integrity 
There was a significant drop (p< 0.0001) in levels of 
GPx and significant increase (p< 0.0001) in GST levels 
in renal tissue of mice induced with B(a)P toxicity as 
compared to normal control mice. Chronic treatment 
with mangiferin (10.0 and 20.0 mg/kg) followed by 
single dose of B(a)P (125.0 mg/kg) significantly 
increased (p< 0.0001) GPx level and  significantly 
decreased GST level (p< 0.0001) in renal tissue 
compared to toxic control mice. In addition, chronic 
Sinha et al                                                                                                               Journal of Drug Delivery & Therapeutics. 2018; 8(1):92-97                   
ISSN: 2250-1177                                                                               [95]                                                                              CODEN (USA): JDDTAO 
treatment with mangiferin alone (20.0 mg/kg) in mice 
significantly increased (p< 0.0001) GPx levels and 
significantly decreased (p< 0.0001) GST level in renal 
tissue (Table 1). 
 
Table 1: Effect of mangiferin pretreatment on B(a)P mediated alteration in glutathione peroxidase and 
glutathione-S-transferase enzymes 
Groups Treatment 
Glutathione peroxidase 
(nmol NADPH 
oxidized/min/mg protein) 
Glutathione-S transferase 
(nmol CDNB conjugate 
formed/min/mg protein ) 
Normal Control Corn oil  (p.o., 7 d) 80.32 ± 0.59 208.63 ± 1.20 
Toxic Control B(a)P  (125.0 mg/g, once) 39.81 ± 0.21
*
 432.74 ± 2.69
*
 
B(a)P + M (10) 
Mangiferin (10.0 mg/kg, i.p., 7 d) + 
B(a)P (125.0 mg/g, once) 
54.53 ± 0.28
#
 335.12 ± 1.75
#
 
B(a)P + M (20) 
Mangiferin (20.0 mg/kg, i.p., 7 d) + 
B(a)P (125.0 mg/g, once) 
71.86 ± 0.40
#
 263.39 ± 1.44
#
 
M (20) Mangiferin (20.0 mg/kg, i.p., 7 d) 98.45 ± 0.59
#
 212.37 ± 1.84
#
 
Results are expressed as Mean ± S.E.M.; n = 6 in each group. Data was analyzed by one way ANOVA followed by Tukey’s test. 
Significance: 
*
p< 0.0001 when compared with normal control group;
 #
p< 0.0001 when compared with toxic control group. B(a)P: 
benzo(a)pyrene; M: mangiferin. 
 
Assessment of DNA integrity 
DNA alkaline unwinding assay exhibit a significant 
decrease (p< 0.0001) in F-value for the toxic control 
group in comparison to the normal mice, which is a 
marker for alteration in DNA integrity. The F-value was 
inversely proportional to the number of strand breaks 
present and thus has been used as an indicator of DNA 
integrity. Chronic treatment with mangiferin (10.0 and 
20.0 mg/kg) followed by single dose of B(a)P (125.0 
mg/kg) significantly increased (p< 0.01 and p< 0.0001 
respectively) F-values compared to toxic control mice. 
In addition, chronic treatment with mangiferin alone 
(20.0 mg/kg) in mice significantly increased (p< 0.0001) 
F-values compared to toxic control mice (Figure 1). 
The effect of pretreatment of mangiferin on B(a)P 
induced micronuclei formation in mouse bone marrow 
cells has been shown in Table 2. Mangiferin treatment at 
both doses (10.0 and 20.0 mg/kg) showed marked 
inhibition (p< 0.0001) in micronuclei formation at both 
doses (Table 2). 
F
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Figure 1: Effect of mangiferin pretreatment on B(a)P 
induced DNA damage in mouse renal tissue using 
alkaline unwinding assay 
Results are expressed as Mean ± S.E.M.; n = 6 in each group. Data 
was analyzed by one way ANOVA followed by Tukey’s test. 
Significance: 
*
p< 0.0001 when compared with normal control 
group; 
%
p< 0.01 when compared with toxic control group;
 #
p< 
0.0001 when compared with toxic control group. NC: normal 
control group, TC: toxic control group; B(a)P: benzo(a)pyrene; M: 
mangiferin. 
 
 
Table 2: Effect of mangiferin pretreatment on B(a)P induced micronuclei formation in mouse bone marrow cells 
Groups Treatment 
Number of 
counted 
nucleated cells 
Number 
of PCE’s 
Number of 
PCE’s with 
micronuclei 
Percent 
of PCE’s 
Percent of 
PCE’s with 
micronuclei 
Normal 
Control 
Corn oil  (p.o., 7 d) 1947 412 26 
21.16 ± 
0.12 
6.31 ± 0.03 
Toxic 
Control 
B(a)P  (125.0 mg/g, once) 1980 551 67 
27.82 ± 
0.34
*
 
12.15 ± 0.06
*
 
B(a)P + 
M (10) 
Mangiferin (10.0 mg/kg, i.p., 7 
d) + B(a)P (125.0 mg/g, once) 
1893 463 42 
24.45 ± 
0.11
#
 
9.07 ± 0.05
#
 
B(a)P + 
M (20) 
Mangiferin (20.0 mg/kg, i.p., 7 
d) + B(a)P (125.0 mg/g, once) 
1954 431 30 
22.05 ± 
0.09
#
 
6.96 ± 0.02
#
 
M (20) 
Mangiferin 
(20.0 mg/kg, i.p., 7 d) 
1966 406 24 
20.65 ± 
0.13
#
 
5.91 ± 0.03
#
 
Results are expressed as Mean ± S.E.M.; n = 6 in each group. Data was analyzed by one way ANOVA followed by Tukey’s test. 
Significance: 
*
p< 0.0001 when compared with normal control group;
 #
p< 0.0001 when compared with toxic control group. PCEs: 
polychromatic erythrocytes; B(a)P: benzo(a)pyrene; M: mangiferin. 
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DISCUSSION 
The present study revealed that the treatment with B(a)P 
at the dose of 125.0 mg/kg significantly caused renal 
damage as assessed by monitoring mitochondrial and 
DNA integrity. B(a)P treatment significantly decreased 
GPx level and increased GST level in renal tissue. In 
addition, DNA alkaline unwinding assay exhibit a 
significant decrease in F-value and increased 
micronuclei formation in the B(a)P treated group. 
Pretreatment with mangiferin restored all the impaired 
conditions. 
B(a)P is the most commonly studied mutagen with 
sources of exposure including occupation, diet and 
tobacco smoke. Our observations clearly indicate a 
compromised antioxidant defense system, inflammation 
and a state of oxidative stress in the renal tissues of 
B(a)P-exposed mice. The present observations are in 
agreement with the previous reports that B(a)P exposure 
induced oxidative stress and inflammation in rodents.
18
 
The covalent binding of carcinogens to DNA is an 
important step in the cancer initiation process, with 
B(a)P requiring metabolic activation for DNA adduct 
formation to occur.
19 
The activation of carcinogens is 
primarily catalyzed by phase I enzymes, protection may 
be accomplished by inhibition of activating enzymes 
and/or by induction of phase II enzymes which leads to 
detoxification and accelerated excretion of 
carcinogens.
20 
Hence, both phase 1 enzyme (GPx) and 
phase II enzyme (GST) have been considered in present 
study.  
Ample biomarkers existing for assessing genotoxicity, 
which is often measured as the representative of cancer. 
Previous studies indicate that that B(a)P treatment leads 
to genotoxicity, chromosomal abbreviations, 
micronuclei induction, DNA adduct formation, strand 
breaks, etc. in a rodent model of experiment.
15
 It is 
evident from this study that mangiferin was suppressed 
the formation of micronuclei polychlorinated 
erythrocytes in vivo, which are the hallmarks of B(a)P 
induced genotoxicity.
7
 Mouse bone marrow 
micronucleus assay is a widely used genotoxic assay to 
detect both clastogenic and aneugenic potencies of 
genotoxic agents or radiation.
21 
Chromosomal 
modifications with development of micronuclei may 
serve as an effective biomarker to assess cancer risk. 
This study revealed an increased number of micronuclei 
in PCE in comparison with the control group indicating 
that B(a)P produces chromosomal damage in 
erythrocytes of bone marrow and this damage is 
associated with the appearance and/or progression of 
tumors with adverse reproductive and developmental 
outcomes. These changes are in agreement with previous 
studies.
22
 In present study, it is evident from the results 
that mangiferin reduced the number of micronuclei in 
comparison with the B(a)P toxic group. 
In conclusion, mangiferin amelioration of B(a)P-induced 
renal toxicity is attributed to the enhancement 
antioxidant defense mechanism and improvement in the 
genotoxic procedure. Thus, supplementation and/or 
treatment with mangiferin could exert protective effects 
against renal toxicity resulting from B(a)P exposure. 
However, further studies are required in order to gain 
more insight at molecular level. 
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